Intellia Therapeutics, Inc. Annual Costs and Expenses in USD from 2015 to 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Intellia Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2015 to 2024.
  • Intellia Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2025 was $124M, a 14.9% decline year-over-year.
  • Intellia Therapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2025 was $565M, a 0.9% decline year-over-year.
  • Intellia Therapeutics, Inc. annual Costs and Expenses for 2024 was $592M, a 7.36% increase from 2023.
  • Intellia Therapeutics, Inc. annual Costs and Expenses for 2023 was $552M, a 8.09% increase from 2022.
  • Intellia Therapeutics, Inc. annual Costs and Expenses for 2022 was $510M, a 69.6% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $592M +$40.6M +7.36% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $552M +$41.3M +8.09% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $510M +$209M +69.6% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $301M +$106M +54.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $195M +$45.1M +30.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $149M +$28.2M +23.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $121M +$25.6M +26.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $95.7M +$47M +96.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $48.6M +$29.2M +150% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $19.5M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.